User profiles for Yoshiki Arakawa

Yoshiki Arakawa

Department of Neurosurgery, Kyoto University Graduate School of Medicine
Verified email at kuhp.kyoto-u.ac.jp
Cited by 5183

Control of axon elongation via an SDF-1α/Rho/mDia pathway in cultured cerebellar granule neurons

Y Arakawa, H Bito, T Furuyashiki, T Tsuji… - The Journal of cell …, 2003 - rupress.org
Rho–GTPase has been implicated in axon outgrowth. However, not all of the critical steps
controlled by Rho have been well characterized. Using cultured cerebellar granule neurons, …

[HTML][HTML] Vorasidenib in IDH1-or IDH2-mutant low-grade glioma

…, M Holdhoff, AF Hottinger, Y Arakawa… - … England Journal of …, 2023 - Mass Medical Soc
Background Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas are malignant brain
tumors that cause considerable disability and premature death. Vorasidenib, an oral brain-…

The Rho-mDia1 pathway regulates cell polarity and focal adhesion turnover in migrating cells through mobilizing Apc and c-Src

N Yamana, Y Arakawa, T Nishino… - … and cellular biology, 2006 - Taylor & Francis
Directed cell migration requires cell polarization and adhesion turnover, in which the actin
cytoskeleton and microtubules work critically. The Rho GTPases induce specific types of actin …

[PDF][PDF] The release of vaccinia virus from infected cells requires RhoA-mDia modulation of cortical actin

Y Arakawa, JV Cordeiro, S Schleich, TP Newsome… - Cell host & …, 2007 - cell.com
Prior to being released from the infected cell, intracellular enveloped vaccinia virus particles
are transported from their perinuclear assembly site to the plasma membrane along …

Multiple spatiotemporal modes of actin reorganization by NMDA receptors and voltage-gated Ca2+ channels

T Furuyashiki, Y Arakawa… - Proceedings of the …, 2002 - National Acad Sciences
Cytoskeleton is believed to contribute to activity-dependent processes underlying neuronal
plasticity, such as regulations of cellular morphology and localization of signaling proteins. …

A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma

Y Narita, Y Arakawa, F Yamasaki, R Nishikawa… - Neuro …, 2019 - academic.oup.com
Background We conducted a phase III trial of personalized peptide vaccination (PPV) for
human leukocyte antigen (HLA)-A24+ recurrent glioblastoma to develop a new treatment …

Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma

…, M Nagane, K Mishima, Y Terui, Y Arakawa… - Neuro …, 2021 - academic.oup.com
Background The safety, tolerability, efficacy, and pharmacokinetics of tirabrutinib, a second-generation,
highly selective oral Bruton’s tyrosine kinase inhibitor, were evaluated for …

ROCK and mDia1 antagonize in Rho-dependent Rac activation in Swiss 3T3 fibroblasts

…, K Kimura, T Furuyashiki, Y Arakawa… - The Journal of cell …, 2002 - rupress.org
The small GTPase Rho acts on two effectors, ROCK and mDia1, and induces stress fibers
and focal adhesions. However, how ROCK and mDia1 individually regulate signals and …

Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell‐derived neural precursors

M Koyanagi, J Takahashi, Y Arakawa… - Journal of …, 2008 - Wiley Online Library
Rho‐GTPase has been implicated in the apoptosis of many cell types, including neurons,
but the mechanism by which it acts is not fully understood. Here, we investigate the roles of …

Intraoperative dorsal language network mapping by using single‐pulse electrical stimulation

…, R Matsumoto, T Kunieda, Y Arakawa… - Human brain …, 2014 - Wiley Online Library
The preservation of language function during brain surgery still poses a challenge. No
intraoperative methods have been established to monitor the language network reliably. We …